US 8399472
Compositions and methods for inhibition of the JAK pathway
granted A61KA61K31/343A61K31/436
Quick answer
US patent 8399472 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/343, A61K31/436, A61K31/505, A61K31/506